scholarly journals High Incidence of Sexually Transmitted Infections in patients with HIV-infection.

2017 ◽  
Vol 75 (1) ◽  
Author(s):  
Telma Susana Vieira Azevedo
Keyword(s):  
Hiv Infection ◽  
Sexually Transmitted Infections ◽  
Sexually Transmitted ◽  
High Incidence

scholarly journals Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection

JAMA ◽  
2019 ◽  
Vol 321 (14) ◽  
pp. 1380 ◽  
Author(s):  
Michael W. Traeger ◽  
Vincent J. Cornelisse ◽  
Jason Asselin ◽  
Brian Price ◽  
Norman J. Roth ◽  
...  
Keyword(s):  
High Risk ◽  
Hiv Infection ◽  
Sexually Transmitted Infections ◽  
Sexually Transmitted ◽  
Preexposure Prophylaxis

scholarly journals Sexually transmitted infections among HIV positive patients: a five year retrospective study

2019 ◽  
Vol 5 (1) ◽  
pp. 23
Author(s):  
N. Saravanan ◽  
Murugan Swamiappan ◽  
Rajkumar Kannan ◽  
G. Arul Raja
Keyword(s):  
Hiv Infection ◽  
Sexually Transmitted Infections ◽  
Tamil Nadu ◽  
Clinical Manifestations ◽  
Hiv And Aids ◽  
People Living With Hiv ◽  
Hiv Patients ◽  
Sexually Transmitted ◽  
Number Of Patients ◽  
Clinical Records

<p class="abstract"><strong>Background:</strong> Sexually transmitted infections (STIs) are the most well established risk factors for the spread of HIV infection. STIs act as cofactors and facilitators for HIV transmission. The effects of HIV infection on immunity can increase susceptibility to other STIs. The aims and objectives of the study were to determine the prevalence of co-infection of sexually transmitted infections among people living with HIV and AIDS.</p><p class="abstract"><strong>Methods:</strong> A retrospective chart review of the data collected from the clinical records of all HIV patients who had attended the STI clinic of Chengalpattu Medical College, Chengalpattu, Tamil Nadu during the five years period, from January 2013 to December 2017, was carried out. Demographic data, clinical manifestations, co-infection of STIs among HIV patients, laboratory investigations and treatment were collected. The data collected were computed and analyzed statistically.<strong></strong></p><p class="abstract"><strong>Results:</strong> During the study period of 5 years from 2013 to 2017 the total number of patients attended the STI clinic were 10825, among that males were 4534 (41.88%) and females were 6291 (58.12%). STIs/RTIs were seen in 2560 (23.65%) cases among the total number of patients attended. HIV was found to be positive in 294 cases, in that 168 (57.15%) were males and 126 (42.85%) were females. In male HIV patients, 51 (30.36%) had co-infection with other STIs/RTIs. In female HIV patients, 57 (45.24) % had co-infection with other STIs/RTIs. Viral STIs was the common co-infection seen in males and vaginal cervical discharge was common in females.</p><p class="abstract"><strong>Conclusions:</strong> STI/RTI co-infection, both symptomatic and asymptomatic are common among PLHIV. Hence they should be regularly counselled regarding the significance of periodic screening for STI/RTIs avoidance of high risk sexual behaviour.</p>

004. A NEW ERA IN CONTRACEPTIVE DEVELOPMENT: NON-HORMONAL OPTIONS THAT ALSO TARGET SEXUALLY TRANSMITTED INFECTIONS

2010 ◽  
Vol 22 (9) ◽  
pp. 4
Author(s):  
E. Dimitriadis
Keyword(s):  
Sexually Transmitted Infections ◽  
Embryo Implantation ◽  
Dual Role ◽  
Contraceptive Efficacy ◽  
Maternal Deaths ◽  
New Era ◽  
Sexually Transmitted ◽  
Unintended Pregnancies ◽  
High Incidence ◽  
Unwanted Pregnancies

Despite huge increases in access to contraceptives globally more than 700 000 maternal deaths related to unintended pregnancies occurred between 1995 and 2000 mostly in developing countries. Over 80 million women have unintended or unwanted pregnancies annually. Remarkably, there have been no new methods of contraceptives developed in the last 50 years. The extremely high incidence of sexually transmitted infections (STIs) indicates that it is desirable to develop contraceptives that also target STIs. Two interleukin (IL) 6-type cytokines, leukemia inhibitory factor (LIF) and IL11, are obligatory for implantation in mice and are dysregulated in endometrium of some women with infertility. Both LIF and IL11 are also thought to have roles in Chlamydia-induced inflammation which can lead to a multitude of pathologies. LIF and IL11 antagonists were produced and their contraceptive efficacy tested in mice. Polyethylene glycol (PEG) was conjugated to LIF antagonist (LA) or IL11 antagonist (IL11A) to increase their serum half-life. PEGLA injected during the peri-implantation period blocked LIF action in the endometrium and totally prevented embryo implantation while having no embryo toxic effects.1 Similarly, injection of PEGIL11A blocked decidua formation resulting in pregnancy failure.2 In women, vaginally administered drugs preferentially localise to the uterus suggesting that vaginal administration of PEGLA is an appropriate delivery method for contraceptive purposes. Further, vaginally administered PEGLA may be useful as a ‘dual-role’ contraceptive to also block STIs. PEGLA administered via vaginal gel was shown to prevent implantation having minimal effects on non-uterine LIF targets. This is the first study to show the contraceptive efficacy of a PEGylated compound delivered vaginally. It further indicates that PEGLA may be useful as a dual-role contraceptive. Contraceptive trials in non-human primates are currently underway to determine the effect of PEGLA on implantation. If effective, this will offer new opportunities as pharmacological, non-hormonal dual-role contraceptives for women. (1) White CA, Zhang JG, Salamonsen LA, Baca M, Fairlie WD, Metcalf D, Nicola NA, Robb L, Dimitriadis E (2007) Proc Natl Acad Sci USA 104: 19 357–62.(2) Menkhorst E, Salamonsen LA, Robb L, Dimitriadis E (2009) Biol of Reprod 80: 920–927.

The Association of Uncontrolled HIV Infection and Other Sexually Transmitted Infections in Metropolitan Atlanta Youth

2015 ◽  
Vol 34 (5) ◽  
pp. e119-e124 ◽  
Author(s):  
Pamela S. Brownstein ◽  
Scott E. Gillespie ◽  
Traci Leong ◽  
Ann Chahroudi ◽  
Rana Chakraborty ◽  
...  
Keyword(s):  
Hiv Infection ◽  
Sexually Transmitted Infections ◽  
Sexually Transmitted

HIV Infection and Sexually Transmitted Infections in Lithuania

1999 ◽  
Vol 10 (10) ◽  
pp. 677-679 ◽  
Author(s):  
S Chaplinskas ◽  
A Trechiokas
Keyword(s):  
Hiv Infection ◽  
Sexually Transmitted Infections ◽  
Congenital Syphilis ◽  
Epidemiological Survey ◽  
Intravenous Drug Use ◽  
Port City ◽  
Small Country ◽  
Sexually Transmitted ◽  
Kaliningrad Region ◽  
National Control

Lithuania is a small country with a population of 3.7 million. It has recently been released from the yoke of Soviet rule. HIV infection was first identified in 1988 and while the numbers of cases are small, the incidence is beginning to rise precipitously. A National AIDS Centre has been established in the capital, Vilnius, and a nationwide epidemiological survey is underway. Efforts are being made to prevent HIV infection. Sixty one per cent of notified cases of HIV infection are in Klaipéda, a port city adjacent to the Kaliningrad region and the predominant mode of transmission is by intravenous drug use. The majority of cases of AIDS, however, are seen in Vilnius. Sexually transmitted infections (STIs) are poorly controlled and there is no national control strategy. While the incidence of gonorrhoea is declining, new cases of syphilis have been on the increase, reaching 101.4 cases per 100,000 of the population. Cases of congenital syphilis are still seen.

Sexually Transmitted Infections as Risk Factors for HIV Infection Among MSMs: Systematic Review

2008 ◽  
Vol 35 (2) ◽  
pp. 209 ◽  
Author(s):  
Chris Bonell ◽  
Ford Hickson ◽  
Meredith Beaumont ◽  
Peter Weatherburn
Keyword(s):  
Risk Factors ◽  
Systematic Review ◽  
Hiv Infection ◽  
Sexually Transmitted Infections ◽  
Sexually Transmitted
Sign in / Sign up

Export Citation Format

Share Document